Short dual antiplatelet therapy followed by P2Y12 inhibitor monotherapy vs. prolonged dual antiplatelet therapy after percutaneous coronary intervention with second-generation drug-eluting stents: a systematic review and meta-analysis of randomized clinical trials
ConclusionAfter second-generation DES implantation, 1 –3 months of DAPT followed by P2Y12 inhibitor SAPT is associated with lower major bleeding and similar stent thrombosis, all-cause death, myocardial infarction, and stroke compared with prolonged DAPT. Whether P2Y12 inhibitor SAPT is preferable to aspirin SAPT needs further investigation.
Source: European Heart Journal - Category: Cardiology Source Type: research
More News: Angioplasty | Aspirin | Bleeding | Cardiology | Clinical Trials | Coronary Angioplasty | Databases & Libraries | Heart | Heart Attack | Percutaneous Coronary Intervention | Stroke | Thrombosis